Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

UnitedHealth Group has been expanding its business through multiple acquisitions. Its strong profits make it likely that the business will continue growing in the future.

Could UnitedHealth Stock Help You Become a Millionaire?

EMIS Group plc (AIM:EMIS) shares dived 22.3% to 1408p after the connected healthcare software and services company's proposed £1.2bn takeover by UnitedHealth Group Inc (NYSE:UNH) was referred by the UK's Competition and Markets Authority (CMA) to a Phase 2 investigation. Earlier this month UnitedHealth proposed to sell off its Optum UK's Medicines Optimisation and Population Health Management businesses in the UK as a remedy to the CMA's concerns following its Phase 1 investigation.

EMIS slides after CMA refers takeover by UnitedHealth to in-depth probe

UnitedHealth's (UNH) UnitedHealthcare business to lower the use of prior authorization process or preauthorization by almost 20%.

UnitedHealth (UNH) Arm to Reduce Prior Authorization Time

Visa

Walgreens

UnitedHealth Group is America's leading insurer, and it's also a leading employer of physicians. Handling a majority of U.S. credit card network transactions, Visa is the leading payment processor by a long shot.

3 Dow Stocks That Bilionaires Are Buying Hand Over Fist

Apple

VerifyMe, Inc.

Adobe

Fiverr

Alphabet

This year has been nothing if not volatile. Worries of a looming recession – if we're not already in one – continue to spark fear.

7 Growth Stocks That Are Crushing the Market in 2023

Berkshire's portfolio is full of many stocks, but only a handful account for the majority of its value. Having a couple of solid businesses in your portfolio to build around can be key to strong returns.

Be Like Buffett and Build Your Portfolio Like This

Despite trading at higher valuation multiples than its peers, the stock's fair value is between $529 and $720 per share, which is a 10% to 50% upside from current levels. Current economic uncertainty will propel investors to defensive, countercyclical stocks that consistently pay dividends, like UNH. Strong M&A activity in the field in 2023 is a growth catalyst.

UnitedHealth Group: May Seem Overvalued But Significant Upside Still Ahead

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IR) of “a” (Excellent) to UnitedHealth Group Incorporated's (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH] recently issued $1.25 billion 4.250% senior unsecured notes, due 2029, $1.5 billion 4.5% senior unsecured notes, due 2033, $2 billion 5.05% senior unsecured notes, due 2053, and $1.75 billion 5.2% senior unsecured notes, due 2063.

AM Best Assigns Issue Credit Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes and New Shelf Registrations

Bristol-Myers

Comcast

Cintas Corp

Home Depot

Intuit

Lowe's

Mastercard

Pfizer

Toronto-Dominion Bank

This monthly series ranks a selection of dividend growth stocks in Dividend Radar and presents the ten top-ranked stocks for consideration. To rank stocks, I sort them in descending order by quality score and break ties with additional metrics.

10 Dividend Growth Stocks - March 2023

McDonald's

Are these two dow stocks on your radar today?

2 Dow Stocks To Watch Today

NVIDIA

Deere & Company

Progressive

Starbucks

The tech industry continues to hand out pink slips to employees as the threat of a recession grows every day. Yet, despite the clouds in the distance, investors continue to debate whether it's wiser to buy stocks that are poised for growth or ones brimming with value.

7 Established Stocks That Are Poised for Growth in 2023

Amgen

Johnson & Johnson

With 60 years of consecutive annual raises, Johnson & Johnson is one of the most reliable dividend-paying stocks the world has ever known. Amgen is a successful biotechnology company that raised its dividend payout at a blazing pace in recent years and could do so again.

3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now

Allstate

Fidelity National Financial

Lincoln National

Reinsurance Group of America

Insurance stocks are among the more intriguing options in this market. Among the most stable and consistent long-term bets, insurance companies are highly sought after by those with long investing time horizons.

5 Undervalued Insurance Stocks with High Dividend Yields and Low Payout Ratios

Advance Auto Parts

Automatic Data Processing

Cigna

Carlisle Companies

Coterra Energy

Invitation Homes

Lennar

Marathon Petroleum

Monolithic Power Systems

Tyson Foods

Vanguard Dividend Appreciation ETF

This article will focus on DGI stocks that are likely to provide a high rate of dividend growth rather than a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names out of an initial list of nearly 400 dividend stocks.

Our Top 10 Dividend Growth Stocks - March 2023

Centene

Humana

Molina Healthcare

Improved premiums cropping from a solid customer base might aid the Medical-HMO industry. However, an escalating expense level and an acute shortage of nurses are roadblocks.

5 HMO Stocks to Watch Despite Elevated Tech Costs, Nursing Shortage

The average brokerage recommendation (ABR) for UnitedHealth (UNH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable.

Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?

Broadcom

All 5 of these companies pay safe, growing dividends. Dividend growth stocks supercharge the Power of Compounding process.

5 Stocks Growing Their Dividend More Than 10% Per Year

UnitedHealth has become a leader in creating a profitable business model to help bend the healthcare cost curve, and its business model is being adapted by its peers. UnitedHealth is a 4 for 1 winner, combining a preeminent health insurance company, a pharmacy benefits manager PBM, a provider of health services, and a health analytics franchise.

UnitedHealth: Buy - May Not Be A SWAN, But It's A SUN For Me

Cincinnati Financial

Lockheed Martin

Medtronic

PepsiCo

High uncertainty may continue to loom over the stock market, but that doesn't mean you need to stay on the sidelines. Instead, keep your eyes on the long-term, with solid additions to your portfolio, such as the best blue-chip stocks to buy and hold.

7 Blue-Chip Stocks to Buy and Hold for Decades

UnitedHealth (UNH) expects the new Pathways for Aging program to serve around 100,000 people.

UnitedHealth (UNH) Plan in Indiana to Offer Pathways Program

INDIANAPOLIS--(BUSINESS WIRE)--UnitedHealthcare Community Plan of Indiana has been recommended by the state of Indiana, Family and Social Services Administration, as one of four managed care organizations to administer its Pathways for Aging (Pathways) program. Pathways is a new Indiana program that will serve Medicaid beneficiaries who are 60 years and older.

UnitedHealthcare Recommended by the State of Indiana To Serve Its Managed Long-Term Services and Supports Medicaid Beneficiaries

Boeing

Cisco Systems

Chevron

Disney

Dow Inc

"The Dow [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration." – Dow Jones & Co. The highest-yield 10 are March's Dogs of the Dow: JNJ, KO, CSCO, AMGN, CVX, DOW, IBM, WBA, MMM, and VZ, averaging a 4.41% annual yield.

2 March Dogs Of The Dow To Buy, 4 More To Watch

News for UnitedHealth Group Stock (UNH)